Libin Pan
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Gut microbial metabolism of Flutamide attenuates its therapeutic efficacy against prostate cancer.
Journal: Gut microbes
Published: June 08, 2026
Mitochondrial fission-mediated podocyte dysfunction via CaMKII/Drp1 signaling pathways contributes to lenvatinib-induced renal injury.
Journal: Biochemical pharmacology
Published: April 30, 2026
Targeting the Gut-Kidney Axis: Modulation of Gut Microbiota by Traditional Chinese Medicine for Chronic Kidney Disease Management.
Journal: Toxins
Published: October 22, 2025
Multi-omics reveal the key role of gut microbiota metabolism in adenine-induced chronic kidney disease.
Journal: Toxicology and applied pharmacology
Published: October 19, 2025
Metformin alleviates ribociclib-induced lung injury by restoring impaired autophagy via targeting Mucolipin-1.
Journal: Toxicology and applied pharmacology
Published: September 17, 2025
Tongue coating microbiota-based machine learning for diagnosing digestive system tumours.
Journal: Journal of oral microbiology
Published: April 10, 2025
Oral microbiota and gastric cancer: recent highlights and knowledge gaps.
Journal: Journal of oral microbiology
Published: August 20, 2024
Current development of molecular classifications of gastric cancer based on omics (Review).
Journal: International journal of oncology
Published: June 04, 2024
Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression.
Journal: Cell discovery
Published: February 02, 2024
Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway.
Journal: Frontiers in pharmacology
Published: January 13, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026